Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sands

Showing results (161-170 of 513) with videos related to

Pageof 52
Sort By:
Inflammatory Bowel Diseases|January 8, 2019
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3Bruce E Sands, Gert Van Assche, David Tudor, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2006
Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II studyB E Sands, M A Blank, R H Diamond, et al.
Gut|May 12, 2007
The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and DenmarkGilaad G Kaplan, Bo V Pedersen, Roland E Andersson, et al.
Inflammatory Bowel Diseases|February 21, 2018
Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score AnalysisShailja C Shah, Steven Naymagon, Hinaben J Panchal, et al.
ASAIO Transactions|October 1, 1991
Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle crampsV J Canzanello, B Hylander-Rossner, R E Sands, et al.
Nature Reviews. Gastroenterology & Hepatology|April 17, 2023
IL-12 and IL-23 pathway inhibition in inflammatory bowel diseaseBram Verstockt, Azucena Salas, Bruce E Sands, et al.
Retinal Cases & Brief Reports|November 13, 2014
Posterior scleral choristomas and trigeminal lipoma in the organoid nevus syndromeScott C N Oliver, Antonio P Ciardella, Rebecca E Sands, et al.
Gastroenterology|August 30, 2017
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's DiseaseBrian G Feagan, Bruce E Sands, Guillermo Rossiter, et al.
Inflammatory Bowel Diseases|November 25, 2010
Clinical scenarios in IBD: optimizing the use of conventional and biologic agentsStephen B Hanauer, Asher A Kornbluth, Julie Messick, et al.
Gastroenterology|August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practiceBarrett G Levesque, William J Sandborn, Joannie Ruel, et al.
Pageof 52

Showing results (161-170 of 513) with videos related to

Sort By:
Pageof 52
Inflammatory Bowel Diseases|January 8, 2019
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3Bruce E Sands, Gert Van Assche, David Tudor, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2006
Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II studyB E Sands, M A Blank, R H Diamond, et al.
Gut|May 12, 2007
The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and DenmarkGilaad G Kaplan, Bo V Pedersen, Roland E Andersson, et al.
Inflammatory Bowel Diseases|February 21, 2018
Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score AnalysisShailja C Shah, Steven Naymagon, Hinaben J Panchal, et al.
ASAIO Transactions|October 1, 1991
Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle crampsV J Canzanello, B Hylander-Rossner, R E Sands, et al.
Nature Reviews. Gastroenterology & Hepatology|April 17, 2023
IL-12 and IL-23 pathway inhibition in inflammatory bowel diseaseBram Verstockt, Azucena Salas, Bruce E Sands, et al.
Retinal Cases & Brief Reports|November 13, 2014
Posterior scleral choristomas and trigeminal lipoma in the organoid nevus syndromeScott C N Oliver, Antonio P Ciardella, Rebecca E Sands, et al.
Gastroenterology|August 30, 2017
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's DiseaseBrian G Feagan, Bruce E Sands, Guillermo Rossiter, et al.
Inflammatory Bowel Diseases|November 25, 2010
Clinical scenarios in IBD: optimizing the use of conventional and biologic agentsStephen B Hanauer, Asher A Kornbluth, Julie Messick, et al.
Gastroenterology|August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practiceBarrett G Levesque, William J Sandborn, Joannie Ruel, et al.
Pageof 52